Literature DB >> 11121910

5-day vs. 7-day triple therapy with rabeprazole, clarithromycin and amoxicillin for Helicobacter pylori eradication.

H Isomoto1, H Furusu, T Morikawa, Y Mizuta, T Nishiyama, K Omagari, K Murase, K Inoue, I Murata, S Kohno.   

Abstract

AIM: To determine whether a 5-day regimen with rabeprazole, clarithromycin and amoxicillin (RCA) was as effective as a 7-day regimen.
METHODS: A total of 139 H. pylori-infected patients were randomized to receive either a 5-day or 7-day course of rabeprazole 10 mg b.d., clarithromycin 400 mg b.d. and amoxicillin 750 mg b.d. Eradication was assessed by CLO test, histology and 13C-urea breath test.
RESULTS: On the intention-to-treat basis, eradication rates were 66% (46 out of 70) and 84% (58 out of 69) for the 5- and 7-day regimens, respectively (P < 0.05). Using per protocol analysis, eradication rates were 70% (46 out of 66) and 91% (58 out of 64) for the 5- and 7-day regimens, respectively (P < 0.01). Adverse events, which were observed in 14 patients from each group, caused discontinuation of treatment in only two patients, resulting in excellent compliance.
CONCLUSIONS: Our 5-day regimen of RCA yielded inferior results, whereas the 7-day regimen achieved an eradication rate exceeding 90% on the per protocol basis. Therefore, treatment regimens of less than 7 days for proton pump inhibitor-clarithromycin-amoxicillin therapies cannot be recommended.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11121910     DOI: 10.1046/j.1365-2036.2000.00892.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  11 in total

1.  Enhanced production of leptin in gastric fundic mucosa with Helicobacter pylori infection.

Authors:  Yoshito Nishi; Hajime Isomoto; Shigeo Uotani; Chun-Yang Wen; Saburo Shikuwa; Ken Ohnita; Yohei Mizuta; Akio Kawaguchi; Kenichiro Inoue; Shigeru Kohno
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

2.  High concentrations of human beta-defensin 2 in gastric juice of patients with Helicobacter pylori infection.

Authors:  Hajime Isomoto; Hiroshi Mukae; Hiroshi Ishimoto; Yoshito Nishi; Chun-Yang Wen; Akihiro Wada; Ken Ohnita; Toshiya Hirayama; Masamitsu Nakazato; Shigeru Kohno
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

3.  Efficacy of omeprazole and amoxicillin with either clarithromycin or metronidazole on eradication of Helicobacter pylori in Chinese peptic ulcer patients.

Authors:  Wei-Hao Sun; Xi-Long Ou; Da-Zhong Cao; Qian Yu; Ting Yu; Jin-Ming Hu; Feng Zhu; Yun-Liang Sun; Xi-Ling Fu; Han Su
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

4.  Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin.

Authors:  Hajime Isomoto; Hisashi Furusu; Ken Ohnita; Chun-Yang Wen; Kenichiro Inoue; Shigeru Kohno
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

5.  One-year follow-up study of Helicobacter pylori eradication rate with 13C-urea breath test after 3-d and 7-d rabeprazole-based triple therapy.

Authors:  Hwang-Huei Wang; Jen-Wei Chou; Kuan-Fu Liao; Zong-Yi Lin; Hsueh-Chou Lai; Chang-Hu Hsu; Chih-Bin Chen
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

Review 6.  Rabeprazole: an update of its use in acid-related disorders.

Authors:  C I Carswell; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 7.  Is short-term therapy really sufficient to eradicate Helicobacter pylori infection?

Authors:  Ning Zhou; Wei-xing Chen; Wei Zhang; Lan Li; Xi Jin; You-ming Li
Journal:  J Zhejiang Univ Sci B       Date:  2010-09       Impact factor: 3.066

8.  Does delayed gastric emptying shorten the H pylori eradication period? A double blind clinical trial.

Authors:  Mohammad Hassan Emami; Mohammad Mehdi Saberfiroozi; Abbas Arj; Ali Reza Taghavi; Kamran Bagheri-Lankarani; Najaf Dehbashi; Mohammad Reza Fattahi; Mahvash Alizadeh; Mohammad Javad Kaviani; Rahim Bahri-Najafi; Bita Geramizadeh; Abbas Esmaeili
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

9.  Impact of endoscopically minimal involvement on IL-8 mRNA expression in esophageal mucosa of patients with non-erosive reflux disease.

Authors:  Yusei Kanazawa; Hajime Isomoto; Chun-Yang Wen; Ai-Ping Wang; Vladimir A Saenko; Akira Ohtsuru; Fuminao Takeshima; Katsuhisa Omagari; Yohei Mizuta; Ikuo Murata; Shunichi Yamashita; Shigeru Kohno
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

10.  Comparison of five-day Helicobacter pylori eradication regimens: rabeprazole-based and omeprazole-based regimens with and without omeprazole pretreatment.

Authors:  Kyoichi Adachi; Tomoyuki Hashimoto; Shunji Ishihara; Hirofumi Fujishiro; Shuichi Sato; Hiroshi Sato; Yuji Amano; Shuzo Hattori; Yoshikazu Kinoshita
Journal:  Curr Ther Res Clin Exp       Date:  2003-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.